Skip to main content
# Title Research Year
1 Evaluation of Circulating MicroRNA-130b as a novel non-invasive biomarker for hepatocellular carcinoma 2025
2 Value of fibrinogen, fibrinogen to albumin ratio, and blood cell-derived inflammatory indices in patients with systemic sclerosis: A case–control study 2025
3 Role of Prothrombin and Methylenetetrahydrofolate Reductase Gene Polymorphisms as well as Thrombophilia Markers, as Risk Factors for Unexplained Recurrent Miscarriage: A Case-Control Study 2025
4 The Assesment of Matrix Metalloproteinase-1 Genotypes Polymorphism as a Risk Factor For Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Liver Cirrhosis 2024
5 Study of MicroRNA-124 in Patients with Lupus Nephritis. 2024
6 Plasma Metadherin mRNA expression in Bladder Cancer 2024
7 Assessment of long noncoding RNA CCAT1 using real time-polymerase chain reaction in colorectal cancer patients 2024
8 Evaluation of serum levels of vitamin D and CXCL10 in patients with generalized vitiligo and their relation to disease severity 2023
9 Effects of preoperative intravenous glutamine administration on cardiac and renal functions in patients undergoing mitral valve replacement surgeries: A randomized double-blind controlled trial 2023
10 ZBTB16::RARA variant acute promyelocytic leukemia (vAPL) treated with gemtuzumab ozogamicin (GO) with unique pathology and genetic findings 2023